Outcome after percutaneous closure of a patent foramen ovale using the Intrasept™ device: A multi-centre study

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 6, 2008, Pages 822-828

  Luermans, Justin G L M ^a   Post, Martijn C ^a   Schräder, Rainer ^b   Sluysmans, Thierry ^b   Vydt, Tom ^a   Vermeersch, Paul ^c   Chessa, Massimo ^d   Onorato, Eustaquio ^e   Goy, Jean Jacques ^f   Budts, Werner I H L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Markuskrankenhaus ^*  (Belgium)

^c MIDDELHEIM HOSPITAL   (Belgium)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

^e S Orsola Hospital   (Italy)

^f Clinique Cecil   (Switzerland)

Author keywords

Device; Intrasept ; Patent foramen ovale; Transcatheter closure

Indexed keywords

ANTICOAGULANT AGENT; CLOPIDOGREL;

ADOLESCENT; ADULT; AIR EMBOLISM; ARTICLE; ATRIOVENTRICULAR BLOCK; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED STUDY; DEVICE MALPOSITION; DISEASE ASSOCIATION; DRUG WITHDRAWAL; EMBOLISM; EPISTAXIS; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART SURGERY; HEART TAMPONADE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MULTICENTER STUDY; OUTCOME ASSESSMENT; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; SKIN ALLERGY; ST SEGMENT ELEVATION; STROKE; SURGICAL EQUIPMENT; SURGICAL MORTALITY; THROMBOEMBOLISM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT FAILURE; TREATMENT INDICATION;

ADULT; CORONARY CIRCULATION; DISEASE-FREE SURVIVAL; EMBOLISM, PARADOXICAL; EQUIPMENT DESIGN; EUROPE; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RECURRENCE; STROKE; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME;

EID: 43249103126     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21458     Document Type: Article

References (25)

1. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
2. Hausmann D, Mugge A, Becht I, et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992;70:668-672.
3. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318: 1148-1152.
4. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
5. Caes FL, Van Belleghem YV, Missault LH, et al. Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg 1995;59:1559-1561.
6. Falk V, Walther T, Krankenberg H, et al. Trapped thrombus in a patent foramen ovale. Thorac Cardiovasc Surg 1997;45:90-92.
7. Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996;46:1301-1305.
8. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130:1083-1088.
9. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
10. Homma S, DiTullio MR, Sacco RL, et al. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke 2004;35:2145-2149.
11. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004;25:424-430.
12. Post MC, Van DK, Budts W. Percutaneous closure of a patent foramen ovale: Single-centre experience using different types of devices and mid-term outcome. Acta Cardiol 2005;60:515-519.
13. Wahl A, Windecker S, Meier B. Patent foramen ovale: Pathophysiology and therapeutic options in symptomatic patients. Minerva Cardioangiol 2001;49:403-411.
14. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
15. Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.
16. Schwerzmann M, Windecker S, Wahl A, et al. Percutaneous closure of patent foramen ovale: Impact of device design on safety and efficacy. Heart 2004;90:186-190.
17. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med 2003;139:753-760.
18. Bruch L, Parsi A, Grad MO, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: Single-center experience. Circulation 2002;105:2845-2848.
19. Wahl A, Meier B, Haxel B, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001;57:1330-1332.
20. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44: 750-758.
21. Spies C, Strasheim R, Timmermanns I, et al. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder. Eur Heart J 2006;27: 365-371.
22. de Belder MA, Tourikis L, Leech G, et al. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992;69:1316-1320.
23. Di TM, Sacco RL, Gopal A, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117: 461-465.
24. Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62:1399-1401.
25. Souteyrand G, Motreff F, Lusson JR, Rodriguez R, Geoffroy E, Dauphin C, Boire JY, Lamaison D, Cassagnes J. Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler and transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur J Echocardiograph 2006;7:147-154.